قلع الأسنان عند المرضى الخاضعين للعلاج بالوارفارين (دراسة مستقبلية وصفية)
Abstract
دراسة مستقبلية وصفية تمت على 32 مريضاً من مراجعي قسم جراحة الفم والفكين- جامعة تشرين ممن لديهم أمراض قلبية ووعائية مختلفة والخاضعين للعلاج بمميعات الدم(الوارفارين) حيث هدفت الدراسة إلى تحديد قيم INR التي تجعل بالإمكان إجراء قلوع الأسنان لدى هؤلاء المرضى دون إيقاف أو تعديل في جرعات مميعات الدم وبدون تعريض المرضى لخطورة العمل الجراحي ولإتمام هذه الدراسة قمنا باستخدام المتغيرات التالية: نوع العلاج الجراحي, طبيعة الإصابة القلبية, جرعة مميعات الدم, قيم INR, الطرق المستخدمة في الإرقاء الموضعي.
خضع 56.25 % من المرضى لقلوع أسنان مفردة, 25% قلوع متعددة, 18.75% قلوع جراحية وكان القيم الوسطى لل INR 2.38 بتفاوت طبيعي قدره 0.07 وبمعدل التشتت 0.27 وهذا يعني أنه ذو دلالة ضعيفة وبفضل الطرق المستخدمة في الإرقاء الموضعي لم يحدث أي اختلاط نزفي ما بعد العمل الجراحي لذلك بدا لنا بالنتيجة بأن خطورة حدوث حوادث صمات خثرية ناجمة عن وقف مميعات الدم هي أكثر خطورة على حياة المريض من احتمال النزوف في حال عدم إيقافها.
The study is prospective and descriptive. It take place in the department of oral surgery in Tishreen university.
It concerned 32 patients presented a cardiovascular pathology, having required an warfarine therapy, and also need an act of oral surgery. The objective of this study was to determine the INR value making possible to carry out an act of oral surgery without haemorrhagic risk. We exploited the following parameters: identification of the patient, oral state, type of oral surgery, type of cardiopathy, AVK posology, INR value, means haemostasis.
56.25% of our patients had undergone a single extraction, 25% had beneficed multiple extractions, and 18.75% had profited from surgical extraction.
The average value of the INR was 2.38 with an variance of 0.07 and an ecart type of 0.27. In favour of the haemostat means, no haemorrhagic complication post operational was revealed. It is allowed that the risk of thromboembolic accident by stoping the treatment is much more prejudicial than hemorrhagic risk for the patent.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.